The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global B Cell Maturation Antigen Targeted Therapy Market Research Report 2025

Global B Cell Maturation Antigen Targeted Therapy Market Research Report 2025

Publishing Date : Mar, 2025

License Type :

Report Code : 1712575

No of Pages : 91

Ask Your Query

Report Description
Table of Content

Synopsis
The global B Cell Maturation Antigen Targeted Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for B Cell Maturation Antigen Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding B Cell Maturation Antigen Targeted Therapy.
Report Scope
The B Cell Maturation Antigen Targeted Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global B Cell Maturation Antigen Targeted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the B Cell Maturation Antigen Targeted Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Johnson & Johnson
Amgen
Seagen
AbbVie
Novartis
BioTherapeutics
Celgene
Bluebird Bio
Bristol Mayer Squibb
Carsgen Therapeutics
Juno Therapeutics
Cogent Bioscience
CRISPR Therapeutics
Allogene Therapeutics
Harpoon Therapeutics
Poseida Therapeutics
Segment by Type
Antibody-Drug Conjugates
CAR-T Cells and Bispecific T Cell Engagers
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of B Cell Maturation Antigen Targeted Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibody-Drug Conjugates
1.2.3 CAR-T Cells and Bispecific T Cell Engagers
1.3 Market by Application
1.3.1 Global B Cell Maturation Antigen Targeted Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global B Cell Maturation Antigen Targeted Therapy Market Perspective (2019-2030)
2.2 B Cell Maturation Antigen Targeted Therapy Growth Trends by Region
2.2.1 Global B Cell Maturation Antigen Targeted Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 B Cell Maturation Antigen Targeted Therapy Historic Market Size by Region (2019-2024)
2.2.3 B Cell Maturation Antigen Targeted Therapy Forecasted Market Size by Region (2025-2030)
2.3 B Cell Maturation Antigen Targeted Therapy Market Dynamics
2.3.1 B Cell Maturation Antigen Targeted Therapy Industry Trends
2.3.2 B Cell Maturation Antigen Targeted Therapy Market Drivers
2.3.3 B Cell Maturation Antigen Targeted Therapy Market Challenges
2.3.4 B Cell Maturation Antigen Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top B Cell Maturation Antigen Targeted Therapy Players by Revenue
3.1.1 Global Top B Cell Maturation Antigen Targeted Therapy Players by Revenue (2019-2024)
3.1.2 Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Players (2019-2024)
3.2 Global B Cell Maturation Antigen Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by B Cell Maturation Antigen Targeted Therapy Revenue
3.4 Global B Cell Maturation Antigen Targeted Therapy Market Concentration Ratio
3.4.1 Global B Cell Maturation Antigen Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by B Cell Maturation Antigen Targeted Therapy Revenue in 2023
3.5 B Cell Maturation Antigen Targeted Therapy Key Players Head office and Area Served
3.6 Key Players B Cell Maturation Antigen Targeted Therapy Product Solution and Service
3.7 Date of Enter into B Cell Maturation Antigen Targeted Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 B Cell Maturation Antigen Targeted Therapy Breakdown Data by Type
4.1 Global B Cell Maturation Antigen Targeted Therapy Historic Market Size by Type (2019-2024)
4.2 Global B Cell Maturation Antigen Targeted Therapy Forecasted Market Size by Type (2025-2030)
5 B Cell Maturation Antigen Targeted Therapy Breakdown Data by Application
5.1 Global B Cell Maturation Antigen Targeted Therapy Historic Market Size by Application (2019-2024)
5.2 Global B Cell Maturation Antigen Targeted Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America B Cell Maturation Antigen Targeted Therapy Market Size (2019-2030)
6.2 North America B Cell Maturation Antigen Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024)
6.4 North America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe B Cell Maturation Antigen Targeted Therapy Market Size (2019-2030)
7.2 Europe B Cell Maturation Antigen Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024)
7.4 Europe B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size (2019-2030)
8.2 Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America B Cell Maturation Antigen Targeted Therapy Market Size (2019-2030)
9.2 Latin America B Cell Maturation Antigen Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024)
9.4 Latin America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size (2019-2030)
10.2 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Introduction
11.1.4 GlaxoSmithKline Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Introduction
11.2.4 Johnson & Johnson Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen B Cell Maturation Antigen Targeted Therapy Introduction
11.3.4 Amgen Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.3.5 Amgen Recent Development
11.4 Seagen
11.4.1 Seagen Company Detail
11.4.2 Seagen Business Overview
11.4.3 Seagen B Cell Maturation Antigen Targeted Therapy Introduction
11.4.4 Seagen Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.4.5 Seagen Recent Development
11.5 AbbVie
11.5.1 AbbVie Company Detail
11.5.2 AbbVie Business Overview
11.5.3 AbbVie B Cell Maturation Antigen Targeted Therapy Introduction
11.5.4 AbbVie Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.5.5 AbbVie Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis B Cell Maturation Antigen Targeted Therapy Introduction
11.6.4 Novartis Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.6.5 Novartis Recent Development
11.7 BioTherapeutics
11.7.1 BioTherapeutics Company Detail
11.7.2 BioTherapeutics Business Overview
11.7.3 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Introduction
11.7.4 BioTherapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.7.5 BioTherapeutics Recent Development
11.8 Celgene
11.8.1 Celgene Company Detail
11.8.2 Celgene Business Overview
11.8.3 Celgene B Cell Maturation Antigen Targeted Therapy Introduction
11.8.4 Celgene Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.8.5 Celgene Recent Development
11.9 Bluebird Bio
11.9.1 Bluebird Bio Company Detail
11.9.2 Bluebird Bio Business Overview
11.9.3 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Introduction
11.9.4 Bluebird Bio Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.9.5 Bluebird Bio Recent Development
11.10 Bristol Mayer Squibb
11.10.1 Bristol Mayer Squibb Company Detail
11.10.2 Bristol Mayer Squibb Business Overview
11.10.3 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Introduction
11.10.4 Bristol Mayer Squibb Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.10.5 Bristol Mayer Squibb Recent Development
11.11 Carsgen Therapeutics
11.11.1 Carsgen Therapeutics Company Detail
11.11.2 Carsgen Therapeutics Business Overview
11.11.3 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Introduction
11.11.4 Carsgen Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.11.5 Carsgen Therapeutics Recent Development
11.12 Juno Therapeutics
11.12.1 Juno Therapeutics Company Detail
11.12.2 Juno Therapeutics Business Overview
11.12.3 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Introduction
11.12.4 Juno Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.12.5 Juno Therapeutics Recent Development
11.13 Cogent Bioscience
11.13.1 Cogent Bioscience Company Detail
11.13.2 Cogent Bioscience Business Overview
11.13.3 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Introduction
11.13.4 Cogent Bioscience Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.13.5 Cogent Bioscience Recent Development
11.14 CRISPR Therapeutics
11.14.1 CRISPR Therapeutics Company Detail
11.14.2 CRISPR Therapeutics Business Overview
11.14.3 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Introduction
11.14.4 CRISPR Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.14.5 CRISPR Therapeutics Recent Development
11.15 Allogene Therapeutics
11.15.1 Allogene Therapeutics Company Detail
11.15.2 Allogene Therapeutics Business Overview
11.15.3 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Introduction
11.15.4 Allogene Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.15.5 Allogene Therapeutics Recent Development
11.16 Harpoon Therapeutics
11.16.1 Harpoon Therapeutics Company Detail
11.16.2 Harpoon Therapeutics Business Overview
11.16.3 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Introduction
11.16.4 Harpoon Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.16.5 Harpoon Therapeutics Recent Development
11.17 Poseida Therapeutics
11.17.1 Poseida Therapeutics Company Detail
11.17.2 Poseida Therapeutics Business Overview
11.17.3 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Introduction
11.17.4 Poseida Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
11.17.5 Poseida Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antibody-Drug Conjugates
Table 3. Key Players of CAR-T Cells and Bispecific T Cell Engagers
Table 4. Global B Cell Maturation Antigen Targeted Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global B Cell Maturation Antigen Targeted Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global B Cell Maturation Antigen Targeted Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global B Cell Maturation Antigen Targeted Therapy Market Share by Region (2019-2024)
Table 8. Global B Cell Maturation Antigen Targeted Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global B Cell Maturation Antigen Targeted Therapy Market Share by Region (2025-2030)
Table 10. B Cell Maturation Antigen Targeted Therapy Market Trends
Table 11. B Cell Maturation Antigen Targeted Therapy Market Drivers
Table 12. B Cell Maturation Antigen Targeted Therapy Market Challenges
Table 13. B Cell Maturation Antigen Targeted Therapy Market Restraints
Table 14. Global B Cell Maturation Antigen Targeted Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global B Cell Maturation Antigen Targeted Therapy Market Share by Players (2019-2024)
Table 16. Global Top B Cell Maturation Antigen Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B Cell Maturation Antigen Targeted Therapy as of 2023)
Table 17. Ranking of Global Top B Cell Maturation Antigen Targeted Therapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by B Cell Maturation Antigen Targeted Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players B Cell Maturation Antigen Targeted Therapy Product Solution and Service
Table 21. Date of Enter into B Cell Maturation Antigen Targeted Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global B Cell Maturation Antigen Targeted Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global B Cell Maturation Antigen Targeted Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global B Cell Maturation Antigen Targeted Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global B Cell Maturation Antigen Targeted Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. GlaxoSmithKline Company Detail
Table 47. GlaxoSmithKline Business Overview
Table 48. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Product
Table 49. GlaxoSmithKline Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 50. GlaxoSmithKline Recent Development
Table 51. Johnson & Johnson Company Detail
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Product
Table 54. Johnson & Johnson Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. Amgen Company Detail
Table 57. Amgen Business Overview
Table 58. Amgen B Cell Maturation Antigen Targeted Therapy Product
Table 59. Amgen Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 60. Amgen Recent Development
Table 61. Seagen Company Detail
Table 62. Seagen Business Overview
Table 63. Seagen B Cell Maturation Antigen Targeted Therapy Product
Table 64. Seagen Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 65. Seagen Recent Development
Table 66. AbbVie Company Detail
Table 67. AbbVie Business Overview
Table 68. AbbVie B Cell Maturation Antigen Targeted Therapy Product
Table 69. AbbVie Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 70. AbbVie Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis B Cell Maturation Antigen Targeted Therapy Product
Table 74. Novartis Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. BioTherapeutics Company Detail
Table 77. BioTherapeutics Business Overview
Table 78. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Product
Table 79. BioTherapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 80. BioTherapeutics Recent Development
Table 81. Celgene Company Detail
Table 82. Celgene Business Overview
Table 83. Celgene B Cell Maturation Antigen Targeted Therapy Product
Table 84. Celgene Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 85. Celgene Recent Development
Table 86. Bluebird Bio Company Detail
Table 87. Bluebird Bio Business Overview
Table 88. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Product
Table 89. Bluebird Bio Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 90. Bluebird Bio Recent Development
Table 91. Bristol Mayer Squibb Company Detail
Table 92. Bristol Mayer Squibb Business Overview
Table 93. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Product
Table 94. Bristol Mayer Squibb Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 95. Bristol Mayer Squibb Recent Development
Table 96. Carsgen Therapeutics Company Detail
Table 97. Carsgen Therapeutics Business Overview
Table 98. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Product
Table 99. Carsgen Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 100. Carsgen Therapeutics Recent Development
Table 101. Juno Therapeutics Company Detail
Table 102. Juno Therapeutics Business Overview
Table 103. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Product
Table 104. Juno Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 105. Juno Therapeutics Recent Development
Table 106. Cogent Bioscience Company Detail
Table 107. Cogent Bioscience Business Overview
Table 108. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Product
Table 109. Cogent Bioscience Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 110. Cogent Bioscience Recent Development
Table 111. CRISPR Therapeutics Company Detail
Table 112. CRISPR Therapeutics Business Overview
Table 113. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Product
Table 114. CRISPR Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 115. CRISPR Therapeutics Recent Development
Table 116. Allogene Therapeutics Company Detail
Table 117. Allogene Therapeutics Business Overview
Table 118. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Product
Table 119. Allogene Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 120. Allogene Therapeutics Recent Development
Table 121. Harpoon Therapeutics Company Detail
Table 122. Harpoon Therapeutics Business Overview
Table 123. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Product
Table 124. Harpoon Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 125. Harpoon Therapeutics Recent Development
Table 126. Poseida Therapeutics Company Detail
Table 127. Poseida Therapeutics Business Overview
Table 128. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Product
Table 129. Poseida Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)
Table 130. Poseida Therapeutics Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global B Cell Maturation Antigen Targeted Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global B Cell Maturation Antigen Targeted Therapy Market Share by Type: 2023 VS 2030
Figure 3. Antibody-Drug Conjugates Features
Figure 4. CAR-T Cells and Bispecific T Cell Engagers Features
Figure 5. Global B Cell Maturation Antigen Targeted Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global B Cell Maturation Antigen Targeted Therapy Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. B Cell Maturation Antigen Targeted Therapy Report Years Considered
Figure 11. Global B Cell Maturation Antigen Targeted Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global B Cell Maturation Antigen Targeted Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global B Cell Maturation Antigen Targeted Therapy Market Share by Region: 2023 VS 2030
Figure 14. Global B Cell Maturation Antigen Targeted Therapy Market Share by Players in 2023
Figure 15. Global Top B Cell Maturation Antigen Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B Cell Maturation Antigen Targeted Therapy as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by B Cell Maturation Antigen Targeted Therapy Revenue in 2023
Figure 17. North America B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America B Cell Maturation Antigen Targeted Therapy Market Share by Country (2019-2030)
Figure 19. United States B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe B Cell Maturation Antigen Targeted Therapy Market Share by Country (2019-2030)
Figure 23. Germany B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Share by Region (2019-2030)
Figure 31. China B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America B Cell Maturation Antigen Targeted Therapy Market Share by Country (2019-2030)
Figure 39. Mexico B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Share by Country (2019-2030)
Figure 43. Turkey B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. GlaxoSmithKline Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 46. Johnson & Johnson Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 47. Amgen Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 48. Seagen Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 49. AbbVie Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 51. BioTherapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 52. Celgene Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 53. Bluebird Bio Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 54. Bristol Mayer Squibb Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 55. Carsgen Therapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 56. Juno Therapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 57. Cogent Bioscience Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 58. CRISPR Therapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 59. Allogene Therapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 60. Harpoon Therapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 61. Poseida Therapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business:

Since 2015

Pre Sales Support:

24*7

Post Sales Support:

24*7

Turn Around Time:

Usually 2 Hours

Clients Served:

425 and counting

Clients Assisted:

1750 and counting

Client Types:

Govt Projects, Private Companies, Consultant and Individuals

Payment:

Partners with:

Number of reports:

1,000,000 and counting

Custom Research:

Available

Report Availability:

Global and Regional Reports

Report Delivery Format:

Usually PDF

Security:

Latest Life Science Market Reports

Global Support Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Hospital OT and X-Ray, Cathode Room Doors (Hermetically Sealed Door) Market Research Report 2025

Global Children\'s DHA Market Research Report 2025

Global Marine Derived Drugs Market Research Report 2025

Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Payments Accepted From

Connect with us at

Complete Secure Website

#socialicons>a span { top: 0px; left: -100%; -webkit-transition: all 0.3s ease; -moz-transition: all 0.3s ease-in-out; -o-transition: all 0.3s ease-in-out; -ms-transition: all 0.3s ease-in-out; transition: all 0.3s ease-in-out;} #socialicons>ahover div{left: 0px;}